We Work With:
- Psychiatrists
- Therapists
- Psychologists
- Neurologists
- Pain Specialists
- Primary Care Physicians
- Coaches
- Social Workers
Treatments for:
- Depression
- Anxiety
- PTSD
- Migraines & Headaches
- CRPS & Chronic Pain
- Immunity & Resilience
Our Services:
- IV Ketamine
- Spravato (intranasal Ketamine)
- Stellate Ganglion Blocks (SGB)
- IV Nutrients & Vitamins
- IV NAD+
- IV Glutathione
- Ketamine Assisted Psychotherapy (KAP)
- Life Skills Coaching
Let us help you support your patients!
We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention.
Research Papers
Ketamine for the Treatment of Chronic Migraines
Intravenous (IV) ketamine has been previously used to treat various refractory pain conditions. We present a series of patients with refractory migraine treated with intravenous ketamine in the hospital setting.
How Ketamine Cures Depression: The Science Behind It
Like many other drugs, ketamine has multiple effects rendering it suitable for various indications including anesthesia, sedation, acute and chronic pain relief and treatment of therapy-resistant depression.
Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
A single subanesthetic dose of ketamine, an NMDA receptor antagonist, leads to fast-acting antidepressant effects.
![Portrait of woman holding black and white younger photo of herself - Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age](https://i0.wp.com/citclinics.com/wp-content/uploads/2021/01/NAD1.jpg?fit=600%2C416&ssl=1 "Portrait of woman holding black and white younger photo of herself - Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age")
Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age
High levels of oxidative damage results in key cellular changes including a reduction in available nicotinamide adenine dinucleotide (NAD+), an essential molecule required for a number of vital cellular processes including DNA repair, immune signaling and epigenetic processing.
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression
Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, has shown rapid antidepressant effects, but small study groups and inadequate control conditions in prior studies have precluded a definitive conclusion. The authors evaluated the rapid antidepressant efficacy of ketamine in a large group of patients with treatment-resistant major depression.
Ketamine to Treat Obsessive-Compulsive Disorder (OCD)
As converging evidence suggests a role for the glutamate system in the pathophysiology of OCD, we tested whether a single dose of ketamine, a non-competitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, could achieve rapid antiobsessional effects.
Ketamine and Depression: From Despair to Hope in Hours
Carlos Zarate, M.D., speeds up treatment for major depression at the National Institutes of Health (NIH) Intramural Research Program (IRP). Dr. Zarate is Chief of the Experimental Therapeutics & Pathophysiology Branch and the Section on the Neurobiology and Treatment of Mood Disorders at the National Institute of Mental Health (NIMH).
Yale University School of Medicine: Ketamine for Depression
A notable recent discovery shows that ketamine, a N-methyl-D-aspartate receptor antagonist, produces rapid (within hours) antidepressant responses in patients who are resistant to typical antidepressants.